Regulatory Affairs Services help companies to ensure their compliance with government regulations and industry standards. Product registration is the process of applying for regulatory approvals with appropriate authorities and getting approval.

Any pharmaceutical or biological product intended for human use should be registered with the Health Authorities as per country-specific requirements. The Regulatory requirements vary at a global level, with every region, every Health Authority (HA) and every product category. Be it data requirements and integration, clinical trial phases and methodology, device classifications and Unique Device Identification (UDI) requirements, ingredient assessment and formulation reviews, data publishing and submission formats (either electronic or paper), every single procedure is unique and aligned with region-specific requirements. Given the intricacies of regional/local requirements, it is indeed a complex situation for manufacturers to ensure that they adopt the right path. As Regulatory submission(s) requirements are dynamic and different for each Health Authorities, they are being updated regularly by the Regulatory affairs services expert who has a thorough understanding of the requirements and keeps track of the updates. It is essential to manage the Regulatory submissions to avoid any rejections and to ensure on-time approvals.

Adding to these global and regional procedural complexities, a handful of end-to-end Regulatory service providers make the situation even more critical for manufacturers seeking in-time global expansion in a cost-effective way. For example, if a US-based drug manufacturer is interested in marketing their product in the Middle East, they may require a service provider who has complete knowledge of the Middle East Pharma Regulatory market space along with some knowledge of a customizable suite of Regulatory services spanning across strategy to submissions, rather than a regular service provider who has expertise in only a single Regulatory function, and might incur huge costs for the drug manufacturer.

The regulatory affairs process is a critical component of the safe development, registration and commercialization of pharmaceuticals. There are numerous factors to consider when developing a strategy for regulatory affairs, including information management, scientific writing, clinical trial design and conduct, regulatory submissions, pharmacovigilance activities as well as interactions with regulators from multiple jurisdictions.

Barrco Regulatory Solutions, as a proven Regulatory affairs consultant for many global manufacturers in their Regulatory submissions, can provide end-to-end Regulatory affairs services to medicinal products manufacturers.